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ABSTRACT 
Epidermal growth factor (EGF) and insulin induced similar effects 
in isolated rat adipocytes. To determine whether EGF and insulin 
produced similar effects through the same mechanisms, we focused on 
lipolysis. Insulin inhibited the lipolysis stimulated by isoproterenol, 
glucagon (either alone or in combination with adenosine deaminase), 
adenosine deaminase itself, or forskolin. In contrast, EGF did not 
inhibit the lipolysis stimulated by forskolin or by hormones when the 
cells were also incubated with adenosine deaminase. The effect of 
insulin, but not that of EGF, on isoproterenol-stimulated lipolysis 
disappeared when adipocytes were incubated with 1 P~VI wortmannin. 
These results indicate that EGF and insulin affected lipolysis through 
different mechanisms. We observed that EGF, but not insulin, in- 
creased cytosolic Ca *+ The effect of EGF, but not that of insulin, . 
disappeared when the cells were incubated in a Ca*+-free medium. 
We suggest that EGF, but not insulin, mediate its antilipolytic effect 
through a Ca *+-dependent mechanism which, however, do not involve 
Ca*+-activated protein kinase C isoforms. This is based on the fol- 
lowing: 1) phorbol 12-myristate 13-acetate affected lipolysis in an 
opposite way to that of EGF; and 2) the protein kinase C inhibitor 
bisindolylmaleimide GF 109203X did not affect the antilipolytic ac- 
tion of EGF. Our results indicate that the antilipolytic effect of EGF 
resembles more that of vasopressin than that of insulin. (Endocri- 
nology 137: 4181-4188, 1996) 
E PIDERMAL GROWTH factor (EGF), a small polypep- tide with a mol wt of about 6K, has dual effects in 
adipose tissue. It stimulates proliferation and blocks differ- 
entiation (lipid accretion) of adipocyte precursor cells in cul- 
ture (1) and in viva (2). In contrast, available data indicate that 
in differentiated adipocytes, EGF stimulates lipid accumu- 
lation: EGF increases acetyl-CoA carboxylase activity, stim- 
ulates lipogenesis (3), and inhibits hormone-stimulated li- 
polysis (4). Kurachi et al. (5) found that EGF is involved in the 
induction of obesity in ovariectomized mice. This dual effect 
of EGF (inhibition of preadipocyte differentiation but pro- 
motion of adipogenesis in differentiated adipocytes) was 
observed in cultured 3T3-Ll cells (6). 
of the low K, [cyclic GMP (cGMP) inhibited] phosphodies- 
terase (see Ref. 14 for review). This effect results in a decrease 
in the hormone-induced CAMP signal, in a lower activation 
of protein kinase A, and therefore, of the hormone-sensitive 
lipase, which ultimately leads to reduced lipolysis (15). In the 
last 2 years, several reports suggested that activation of phos- 
phatidylinositol 3-kinase is necessary for the antilipolytic 
action of insulin (16, 17). 
The effects of EGF in differentiated adipocytes are there- 
fore similar to those of insulin. EGF and insulin receptors are 
both ligand-activated tyrosine-kinases (7-9). The autophos- 
phorylated EGF receptor and the phosphorylated IRS-l [the 
main substrate of the insulin receptor (lo)] serve as docking 
points to several SH-2 (for Src homology) domain-containing 
proteins (11). As a result, both EGF and insulin activate the 
Ras/Raf-1 /MAP kinase cascade and other signalling path- 
ways in many cell types (for recent reviews see Refs. 12 and 
13). 
Our previous studies on the antilipolytic effect of EGF 
suggested that this is a consequence of an action at the level 
of the adenylylcyclase control by G proteins rather than an 
activation of some phosphodiesterase (4). However, EGF, 
like insulin, activates phosphatidylinositol 3-kinase in sev- 
eral cell systems (18). The aim of the studies presented here 
was to determine whether insulin and EGF induced their 
antilipolytic effects through the same mechanism. To do so, 
we first compared the effects of EGF and insulin on lipolysis 
stimulated by several mechanisms. Then, we studied the 
involvement of wortmannin-sensitive substrates and of cal- 
cium ions in their antilipolytic effects. The results suggest 
that the effect of EGF on lipolysis resembles more the action 
of vasopressin than that of insulin. 
One of the better known effects of insulin is its interference 
with the lipolytic action of catecholamines in adipose tissue. 
This is a consequence of the phosphorylation and activation 
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Adipocytes were isolated from the epididymis of male Wistar rats as 
indicated in (4). The experimental procedures used were approved by 
the Committee on Animal Care of the University of Barcelona. To de- 
termine glucose oxidation, adipocytes (0.15 X lo6 cells/ml) were incu- 
bated in-i<rebs-Henseleit buff& c&a&g 1 mM CaCl, Ad 3% BSA 
lbuffer Ab suuulemented with 0.1 mM 1’4C1-U-elucose (2.48 Li/moll. 
?he incudatioywas carried out at 37 C in a &al&g wate; bate. tie celis 
were maintained inside capped vials with a small beaker suspended 
*This work was supported by grants (PB91-0251 and PB94-0863) from * from the cap. After 2 h of incubation in the indicated conditions, 0.2 ml 
D.G.I.C.Y.T. (Ministerio de Educaci6n y Ciencia, Spain). of 35% HClO, was injected through the cap into the cell suspension. 
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Another 0.2 ml of methyl benzethonium hydroxide were injected into 
the small beaker to trap the 14C02 produced during the incubation. After 
45 min, the radioactivity was counted, 
Incorporation of glucose into lipids was studied in isolated adipo- 
cytes incubated as indicated above in buffer A containing 0.1 mM [‘“Cl- 
U-glucose (2.48 pCi/mol). After 2 h of incubation, 0.8 ml of the cell 
suspension was placed into 2.5 ml of methanol/ chloroform (2:l by ~01). 
Lipids were extracted and the radioactivity was counted as in (19). 
Lipolysis was determined as the amount of glycerol released from the 
isolated adipocytes during the incubation period. Isolated adipocytes 
were incubated in buffer A supplemented with 5 mM glucose. At the 
beginning and after 30 min of incubation at 37 C, a sample was taken 
and immediately placed into enough HClO, to give a final concentration 
of 3%. Neutralized supernatants were used to determine glycerol (20). 
TO study the effect of insulin and EGF on lipoprotein lipase secretion, 
the cells (lOh cells/ml) were incubated in buffer A supplemented with 
5 mM glucose and a amino acid- and vitamin-solution (21) (buffer B), at 
23 C instead of 37 C because the enzyme released to the incubation 
medium by the cells is rapidly inactivated at this temperature (22). After 
30 min of incubation, a sample was taken, and the cells were separated 
from the medium by centrifugation. The cells were homogenized by 
sonication in (1 ml/5 X lo6 cells) buffer containing 10 rnM HEPES, 1 rnM 
EDTA, 1 mM dithiothreitol, and 5 U heparin/ml, pH 7.4. Lipoprotein 
lipase activity in cells and medium was quantified as in (23). One unit 
of enzyme activity corresponded to the amount of enzyme that catalyzes 
the release of 1 Fmol of oleate per min. 
In experiments where CAMP was to be determined, the incubations 
were performed at 3 X lo” cells/ml. At indicated times a sample (1 ml) 
was obtained and deproteinized as described above for lipolysis. CAMP 
was determined in neutralized supernatant with a radiochemical bind- 
ing assay kit, following manufacturer’s instructions. 
Cytosolic free Ca2+ concentration was determined in Fura-2/AM 
loaded adipocytes. Isolated adipocytes were incubated (lo6 cells/ml) in 
buffer B for 45 min at 37 C in the presence of 5 PM Fura-2/AM. The cells 
were then rinsed three times in fresh Fura-2/AM-free buffer B and 
further incubated for 30 min at 25 C to allow deesterification of the dye, 
and extrusion of the nondeesterified dye. Cell were again rinsed twice 
in fresh buffer B before their fluorescence was monitored in a Shimadzu 
RF5001PC spectrofluorimeter (excitation at 340 and 380 nm and emission 
at 505 nm). At the end of each experiment, 0.06 ml of Triton X-100 and 
0.1 ml of 100 rnM EGTA were sequentially added. Cytosolic free Ca*+ 
was quantified as in Ref. 24. 
EGF was obtained from Boehringer Mannheim (Mannheim, Germa- 
ny); vasopressin, forskolin, and phorbol 12-myristate 13-acetate were 
purchased from Sigma Chemical Co. (St. Louis, MO). Wortmannin was 
obtained from Calbiochem-Novabiochem (La Jolla, CA). Bisindolylma- 
leimide GF 109203X was from Calbiochem (San Diego, CA). All other 
chemicals were obtained as indicated elsewhere (4, 19, 23, 25). The 
results shown in the figures and tables correspond to a representative 
(one among those performed) experiment. In each experiment, every 
condition was incubated in triplicate. Every experiment was repeated at 
least three times with different cell preparations. The significance of the 
differences was determined by ANOVA, unless otherwise indicated. 
When significant F value was obtained, multiple comparisons between 
selected groups were made by Bonferroni test (GraphPad InStat, IS1 
Software, Philadelphia, PA) (26). 
Results 
We first compared the effects of insulin and EGF on adi- 
pocytes. Both peptides stimulated glucose oxidation (68 rt 3 
nmol glucose into 14C0,/ 60 min X lo6 cells in control cells; 
103 2 6 nmol glucose into 14C02/ 60 min X lo6 cells in insulin 
(2 nM)-treated cells, P < 0.001; 83 ? 3 nmol glucose into 
14C02/ 60 min X lo6 cells in EGF (100 nM)-treated cells, P < 
0.01) and incorporation into lipids (43 2 3 nmol glucose into 
lipids/60 min X lo6 cells in control cells; 83 * 5 nmol glucose 
into lipids / 60 min X lo6 cells in insulin (2 nM)-treated cells, 
P < 0.001; 55 -t- 3 nmol glucose into lipids/ 60 min X lo6 cells 
in EGF (100 nM)-treated cells, P < 0.001). These results are in 
keeping with previous results showing that both insulin and 
EGF increased acetyl-CoA carboxylase activity, and the con- 
version of [3H]glucose into lipids (3). 
Adipose tissue can also obtain fatty acids from those es- 
terified in circulating lipoproteins. The enzyme responsible 
for the hydrolysis of esterified fatty acids circulating in both 
chylomicra and very low density lipoproteins is lipoprotein 
lipase (27). Insulin is the most important hormone in the 
regulation of lipoprotein lipase in adipose tissue (28). Here 
we show that EGF, like insulin, stimulated the release of 
lipoprotein lipase from isolated adipocytes into the incuba- 
tion medium: 0.07 2 0.04 mU/ lo6 cells in control cells; 0.48 5 
0.04 mu/lo6 cells in 2 nM insulin-treated cells, P < 0.001; 
0.21 ‘- 0.01 mu/lo6 cells in 100 nM EGF-treated cells, P < 
0.001. The lipoprotein lipase activity associated to the cells 
was not affected by either insulin or EGF treatement (1.44 2 
0.04, 1.22 +- 0.04, and 1.45 2 0.03 mU/ lo6 cells in control, 
insulin-, and EGF-treated cells respectively; nonsignificant 
differences). The effect of insulin or EGF on the secretion of 
lipoprotein lipase into the incubation medium was not ob- 
served when the cells were incubated in the presence of 5 U 
heparin/ml(2.04 + 0.10,2.07 ? 0.04, and 2.16 2 0.10 mu/lo6 
cells in control, insulin-, and EGF-treated cells respectively; 
nonsignificant differences). The rapid, heparin-independent 
effect of insulin on the release of lipoprotein lipase from 
cultured adipocytes was already observed by Chan et al. (29). 
Adachi et al. (6) have recently reported that EGF, at longer 
exposures, increases lipoprotein lipase mRNA in cultured 
3T3-Ll adipocytes. 
The main purpose of our study was to compare the anti- 
lipolytic effect of EGF and insulin. The results shown in Fig. 
1 indicate that maximal doses of insulin or EGF (determined 
in dose-response experiments; data not shown) decreased by 
65% and 40% respectively, the isoproterenol-stimulated li- 
polysis. The addition of a maximal dose of EGF together with 
a maximal dose of insulin further inhibited isoproterenol- 
stimulated lipolysis (Fig. 1). 
Next, we compared the effect of insulin and EGF on li- 
basal IS0 IS0 IS0 IS0 
+Ins +EGF +Ins 
+EGF 
FIG. 1. Insulin and EGF decrease isoproterenol-stimulated lipolysis. 
Isolated adipocytes were incubated at 37 C in a medium containing 
5 mM glucose at the indicated conditions. ISO, 30 nM isoproterenol; 
Ins, 2 nM insulin; EGF, 100 nM EGF. After 30 min of incubation a 
sample was processed to determine glycerol production.The results 
are the mean i SE of triplicate values. *, P < 0.05; ***, P < 0.001. 
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polysis, which was stimulated through different mechanisms 
(see Fig. 2 for a schematic representation of the different 
mechanisms used to stimulate lipolysis in this experiment). 
The results are shown in Table 1. Neither insulin nor EGF 
affected nonstimulated lipolysis. However, insulin was able 
to inhibit lipolysis irrespective of the stimulating agent (ex- 
cept dibutyryl CAMP). EGF did not decrease forskolin-, aden- 
osine deaminase (either alone or in combination with iso- 
proterenol or glucagon)-, or dibutyryl CAMP-stimulated 
lipolysis. 
The use of phosphatidylinositol 3-kinase inhibitors has 
revealed that this enzyme is involved in many actions of 
insulin in adipocytes, such as the stimulation of glucose 
uptake (16), the stimulation of glycogen synthase (30), and 
also the inhibition of hormone-stimulated lipolysis (17). 
Therefore, to determine whether the differences in the anti- 
lipolytic action of insulin and EGF are the consequence of 
differences in the signaling mechanism, we incubated iso- 
lated adipocytes in the absence and in the presence of wort- 
mannin (1 PM) (an inhibitor of phosphatidylinositol3-kinase 
(31)) for 30 min before the addition of hormones. The results 
are shown in Fig. 3. Wortmannin completely abolished the 
antilipolytic effect of insulin. However, the effect of EGF was 
only moderately reduced (30% inhibition without wortman- 
nin, and 25% inhibition in the presence of wortmannin). 
In search of differences in EGF and insulin signaling, we 
focused on Ca’+. First, we studied the effect of EGF on 
cytosolic free Ca ‘+ in Fura-2-loaded adipocytes. As shown in 
Fig. 4, EGF increased cytosolic Ca2+ concentration. We per- 
formed eleven experiments like that shown in Fig. 4. The 
mean basal Ca2+ concentration was 155 t 3 nM (similar basal 
cytosolic Ca2+ concentration was reported by others (32)) 
and increased to 184 + 5 nM after the addition of EGF (P < 
0.001, determined by the paired Student’s t test). This effect 
was, however, quite moderate. As shown in the same Fig. 4, 
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FIG. 2. Schematic representation of the different mechanisms used 
to stimulate lipolysis in experiments shown in Table 2. A,PR, A,- 
purinergic receptor; AC, adenylylcyclase; ADA, adenosine deaminase; 
PAR, p-adrenergic receptor; bt,cAMP, dibutyryl CAMP; Gi, G,-pro- 
tein; GR, glucagon receptor; Gs, G,-protein; HSL: hormone-sensitive 
lipase; ISO: isoproterenol; 5’.Ndase: 5’-Nucleotidase; PDE, phosphod- 
iesterase; PIA, p-(phenylisopropil)adenosine; PKA, protein kinase A 
(CAMP-dependent protein kinase). 
TABLE 1. Insulin and EGF affect differently lipolysis stimulated 
through different mechanisms 
Control Insulin EGF 
Stimulation conditions 
Nonstimulated 
ADA (2 pg/ml) 
IS0 (100 nM) 
IS0 + ADA 
Glucagon (50 nM) 
Glucagon + ADA 
Forskolin (5 KM) 
521 
921 
33 2 2 
71 t 4 
45 f 3 
73 i 5 
57 t- 2 
6t4NS 
5 ? 1” 
17 t 2” 
31 t 2” 
36 k 2” 
58 2 2” 
38 lr 2” 
5?3NS 
9?1NS 
21 2 2h 
73t5NS 
39 5 2’ 
77~5NS 
56?3NS 
bt,-CAMP (350 /LM) 43 t- 2 43+6NS 43tlNS 
Isolated adipocytes were incubated at 37 C in a medium containing 
5 mM glucose with the indicated agents, and in the absence (control) 
or in the presence of either insulin (2 nM) or EGF (100 nM). After 30 
min of incubation, a sample was processed to determine glycerol 
production. The results are the mean + SE of triplicate values. Com- 
parisons were made versus control value. 
a P < 0.01; ’ P < 0.001; (- P < 0.05. NS, nonsignificant differences. 
The production of glycerol in all stimulation conditions was signifi- 
cantly higher than in non-stimulated (basal) condition (comparisons 
not shown). ISO, Isoproterenol; ADA, adenosine deaminase; bt,- 
CAMP, dibutyryl CAMP. 
basal IS0 IS0 IS0 basal IS0 IS0 IS0 
+Ins +EGF +Ins +EGF 
FIG. 3. Wortmannin abolishes the effect of insulin, but not of EGF, 
on isoproterenol-stimulated lipolysis. Isolated adipocytes were incu- 
bated for 30 min without or with 1 pM wortmannin before the addition 
of hormones (zero time). At zero time or 30 min after hormone addi- 
tions (100 nM isoproterenol (ISO) alone or in combination with either 
2 nM insulin or 100 nM EGF), a sample was taken to determine glycerol 
production. The results are the mean + SE of triplicate values. ‘$‘, P < 
0.05. :g* P < 0.01. > 3 
vasopressin raised intracellular Ca2+ concentration to a 
much higher level. When adipocytes were incubated in a 
Ca2 +-free medium, the nonstimulated intracellular Ca’+ con- 
centration decreased. In this condition, EGF did not increase 
cytosolic Ca*+ concentration (Fig. 4), and vasopressin pro- 
duced a more moderate and transient effect. In agreement 
with previous reports (33), we did not observe any effect of 
insulin on intracellular Cazt concentration (data not shown). 
Next, we compared the effects of EGF and vasopressin on 
CAMP concentration and on lipolysis in isolated adipocytes. 
Neither EGF nor vasopressin affected basal CAMP concen- 
tration (1.7 + 0.2, 1.8 -t 0.2, and 1.7 2 0.1 pmol/105 cells in 
control, 100 nM EGF-, and 300 nM vasopressin-treated cells 
respectively; nonsignificant differences) or lipolysis (5.2 + 
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FIG. 4. EGF and vasopressin increase cytosolic Ca2+ in isolated adi- 
pocytes. Isolated adipocytes were loaded with Fura-S/AM and used to 
determine the effect of 100 nM EGF and 30 nM vasopressin on cytosolic 
Ca”+. At the indicated time (arrows) EGF or vasopressin were added. 
Continuous line, cells incubated in medium containing 1 mM CaCI,. 
Dotted line, Cells incubated in medium lacking CaCl, and supple- 
mented with 0.5 mM EGTA. 
0.3,5.0 +- 0.2, and 4.9 -C 0.2 nmol glycerol/30 min x lo5 cells 
in control, EGF-, and vasopressin-treated cells respectively; 
nonsignificant differences). EGF or vasopressin decreased 
both parameters in isoproterenol-stimulated cells (CAMP in 
pmol/105 cells: 4.0 2 0.2, 3.2 t- 0.1, P < 0.01, and 2.8 + 0.1, 
P < 0.001 in 30 nM isoproterenol-, (isoproterenol+EGF)-, and 
(isoproterenol+vasopressin)-treated cells, respectively; li- 
polysis innmol glycerol/30 min X lo5 cells: 19.5 t- 0.7,11.8 2 
0.9, P < 0.01, and 13.0 +- 0.3, P < 0.001 in isoproterenol-, 
(isoproterenol+EGF)-, and (isoproterenol+vasopressin)- 
treated cells respectively). However, none of these parame- 
ters were affected by EGF or vasopressin in forskolin-stim- 
ulated cells (CAMP in pmol/105 cells: 17.4 +- 0.7, 18.1 2 1.7, 
and 16.8 + 0.6 in 5 pM forskolin-, (forskolin+EGF)-, and 
(forskolin+vasopressin)-treated cells respectively, nonsig- 
nificant differences; lipolysis in nmol glycerol / 30 min X lo5 
cells: 57 -f 2, 56 -t 1, and 58 2 1 in forskolin-, 
(forskolin+EGF)-, and (forskolin+vasopressin)-treated cells, 
respectively, nonsignificant differences). 
The antilipolytic effect of EGF and vasopressin were of 
similar magnitude, as shown above, but the increase in cy- 
tosolic Ca*+ was much higher when the cells were stimulated 
with vasopressin than with EGF (see Fig. 4). Therefore, we 
studied the relationship between the increase in cytosolic 
Ca2+ and the antilipolytic effect of vasopressin in a dose- 
response experiment. Vasopressin increased cytosolic Cazt 
in a dose-dependent manner (Fig. 5, upper panel). When we 
plotted the antilipolytic effect in isoproterenol-stimulated 
cells as a function of the peak Ca2+ concentration achieved 
by increasing vasopressin concentration (Fig. 5, lozoev panel), 
we observed that lipolysis was sensitive to a small increase 
in cytosolic Ca2+, and that a larger increase in Cazt did not 
further decrease lipolysis. 
We have shown above that maximal doses of EGF and 
insulin induced an almost additive antilipolytic effect. There- 
fore, we studied whether saturating concentrations of EGF 
, 00 300 500 700 
peak Ca2+ (nM1 
FIG. 5. Relationship between increase in cytosolic Ca2+ and the in- 
hibition of isoproterenol-stimulated lipolysis by vasopressin. Fura-Y 
AM-loaded adipocytes were exposed to increasing concentrations of 
vasopressin and the increase in cytosolic Cazt was monitored (upper 
panel). Simultaneously, other samples of the same cell batch were 
incubated for 30 min in the presence of 50 nM isoproterenol and 
increasing concentrations of vasopressin to determine the effect on 
lipolysis. The lower panel shows the relationship between the peak 
cytosolic Cast concentration (mean -t SE of the next 20 sec. after 
vasopressin addition), and the lipolytic response to isoproterenol 
(mean i SE of triplicate values). 
(100 nM) (4) and vasopressin (300 nM) (see Fig. 5) induced 
additive antilipolytic effects. In this experiment, 100 nM iso- 
proterenol increased lipolysis from a basal 7 2 1 nmol glyc- 
erol/30 min X lo5 cells to 38 t- 2 nmol glycerol/ 30 min X lo5 
cells (P < 0.001). When EGF or vasopressin were added in 
combination with isoproterenol, lipolysis was reduced to 
28 +- 1 and to 28 t- 2 nmol glycerol/30 min X lo5 cells, 
respectively (P < 0.05 7~. isoproterenol value). When both 
EGF and vasopressin were added simultaneously, the iso- 
proterenol-stimulated lipolysis was not further reduced 
(26 -C 1 nmol glycerol/30 min X lo5 cells (differences were 
nonsignificant either ZJS. IS0 + EGF or IS0 + VP). 
Insulin requires the presence of Ca2+ ions in the incubation 
medium to produce maximal effects (34). Therefore, we stud- 
ied the requirement of extracellular Ca2+ for the antilipolytic 
effect of insulin, EGF, and vasopressin. As shown in Fig. 6, 
isoproterenol-stimulated lipolysis was somewhat lower in 
the absence of Ca*+ ions. The antilipolytic effect of insulin 
was also reduced by the lack of Ca2+ (71% inhibition in the 
presence of Ca2+, 58% in its absence). The effects of EGF or 
vasopressin were completely abolished in the absence of 
extracellular Ca2+. In this condition, neither EGF nor vaso- 
pressin interfered with the CAMP signal generated by iso- 
proterenol (data not shown). 
To study the involvement of some of the Ca2+-dependent 
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- Ca’+ + EGTA 
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+Ins +EGF +VP 
FIG. 6. The effects of EGF and vasopressin on isoproterenol-stimu- 
lated lipolysis are Caa+-dependent. Isolated adipocytes were incu- 
bated in a medium containing Caa+ ions (1 mM CaCl,) or in medium 
without Ca2+ ions (no CaCl, and 0.5 rnx EGTA). In each condition, 
the cells were incubated without additions (basal) or in the presence 
of 100 nM isoproterenol alone (ISO), or in combination with 2 nM 
insulin (IS0 + Ins), with 100 nM EGF (IS0 + EGF), or with 30 nM 
vasopressin (IS0 + VP). Results are the mean 2 SE of triplicate 
values. *, P < 0.05; 'bh, P < 0.01; ***, P < 0.001. 
TABLE 2. EGF and PMA have different effects on lipolysis 
CAMP Lipolysis 
(pmoV10” cells) bnol dvceroU30 min X 10” cells) 
basal 
+ PMA (100 nM) 
+ EGF (100 nM) 
IS0 
+ PMA (100 nM) 
+ EGF (100 nM) 
ADA 
+ PMA (100 nM) 
+ EGF (100 nM) 
IS0 + ADA 
+ PMA (100 nM) 
+ EGF (100 nM) 
IS0 + ADA + PIA 
+ PMA (100 nM) 
+ EGF (100 nM) 
1.2 t 0.3 
1.2 t 0.2 
1.2 k 0.2 
4.2 iz 0.2 
5.4 k 0.1” 
3.6 + O.lh 
2.4 t 0.1 
2.8 i 0.1” 
2.4 -t 0.1 
230 t 6 
316 2 22’ 
229 -c 3 
3.2 5 0.4 
4.6 t- 0.2” 
2.4 + 0.2’ 
3 f 1- 
321 
221 
108 i- 1 
130 -t 3” 
65 t 5” 
41 5 1 
80 k 7” 
42 -c 2 
130 2 3 
134 2 2 
130 i 2 
60 t 3 
104 2 gb 
48 -+ 3” 
Isolated adipocytes were incubated in the following conditions: 
ISO: 100 nM isoproterenol; ADA: 2 pg adenosine deaminaselml, IS0 + 
ADA: combination of isoproterenol and adenosine deaminase; IS0 + 
ADA + PIA: combination of isoproterenol, adenosine deaminase and 
10 nMfl-(phenylisopropyl)adenosine. At 10 and 30 min ofincubation, 
a sample was taken to determine cyclic AMP and lipolysis, respec- 
tively. The results are the mean f SE of triplicate values. 
a P < 0.01; h P < 0.05. 
protein kinase C isoforms in the antilipolytic effect of EGF, 
we compared first the effects of EGF and the protein kinase 
C activator phorbol12-myristate 13-acetate (PMA) on CAMP 
and lipolysis. The results are shown in Table 2. EGF de- 
creased isoproterenol-stimulated lipolysis and CAMP only 
when adipocytes were incubated without adenosine deami- 
nase or when, besides adenosine deaminase, the nondegrad- 
able analogue N”-(phenylisopropyl)adenosine (PIA) was 
also added. PMA increased CAMP under any stimulatory 
condition. Lipolysis was also synergistically increased by 
PMA except when it was stimulated by the combination of 
isoproterenol and adenosine deaminase. In this condition, 
lipolysis exceeded 125 nmol glycerol/30 min x lo5 cells. As 
shown in Fig. 7, at this value, an additional increase in CAMP 
did not further increase lipolysis. Honnor et al. (35) also 
reported saturation of lipolysis when studied as a function 
of protein kinase A activity ratio. Figure 7 plots data shown 
in Table 2. Note that control-, PMA-, and EGF-values all fit 
to the same curve. This indicates that the opposite effects of 
PMA and EGF on lipolysis can be explained by their effects 
on CAMP levels. 
We have reported that EGF enhances the sensitivity of the 
G,-mediated activation of adenylylcyclase to the inhibitory 
(G,-mediated) effect of adenosine (4). Therefore, we also com- 
pared the effects of EGF and PMA on the inhibition of iso- 
proterenol-stimulated lipolysis by PIA. As shown in Fig. 8, 
EGF decreased IC,, from control value of 30 t- 2 nM to 11 f- 
1 nM (P < 0.001). EGF does not affect however the maximal 
inhibitory effect of PIA. PMA not only did not decrease IC,,, 
but actually increased this parameter to 39 2 2 nM (P < 0.01). 
PMA also reduced the maximal inhibitory effect of PIA. 
To rule out any role of some of the Ca2+-dependent protein 
kinase C isoforms in EGF inhibition of hormone-stimulated 
lipolysis, we studied the effect of the protein kinase C-in- 
hibitor bisindolylmaleimide GF 109203X (36). The results are 
shown in Table 3. The incubation of adipocytes for 30 min 
with 2 PM GF 109203X completely prevented the effect of 
PMA on isoproterenol-stimulated lipolysis. The effect of EGF 
was, however, insensitive to this protein kinase C inhibitor. 
Discussion 
There are few studies on the effect of EGF in mature 
adipocytes (3-6). The data available suggest that, like insulin, 
EGF may promote lipid accumulation. Here we show that 
EGF and insulin stimulate glucose metabolism (oxidation 
and incorporation into lipids); they also stimulate the release 
of lipoprotein lipase and inhibit catecholamine-stimulated 
FIG. 7. EGF and PMA do not affect the relationship between CAMP 
and lipolysis. Data in Table are plotted in this figure to show the 
relationship between CAMP and lipolysis. 0, Cells incubated in the 
presence of PMA; n, cells incubated in the presence of EGF; 0, control 
cells. 
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FIG. 8. EGF increases, but PMA decreases, the sensitivity of isopro- 
terenol-stimulated lipolysis to inhibition by fl-(phenylisopropyl)ad- 
enosine. The effect of increasing concentrations of PIA on lipolysis 
stimulated by 100 nM isoproterenol plus 2 pg adenosine deaminase/ml 
was determined in the absence of further additions (control: 0) or in 
the presence of either 100 nM EGF (m) or 100 nM PMA (0). Results are 
the mean of duplicate values. 
lipolysis. Therefore, both promote all the actions required for 
the efficient accumulation of triacylglycerols in adipocytes. 
Our findings on the short-term effects of EGF are in keeping 
with those on the long-term effect reported by Adachi et al. 
(6). They showed that EGF actually increased the triacyl- 
glycerol content in 3T3-Ll adipocytes, when the peptide was 
added for 10 days on and after the sixth day after the in- 
duction of differentiation. 
Because antilipolysis is the best known effect among those 
of insulin in adipocytes, we centered our studies on this 
pathway to determine whether EGF and insulin produced a 
similar effect through the same or different mechanism. 
Insulin stimulates the phosphorylation, which results in 
the activation, of one of the phosphodiesterase isoforms: the 
low K, (cGMP inhibited) phosphodiesterase (37). Recent 
studies indicate that this effect is sufficient to account for the 
antilipolytic effect of insulin (38). Our data concerning the 
insulin effect (see Table 1) are compatible with this mode of 
action. Insulin did not decrease dibutyryl CAMP-stimulated 
lipolysis because dibutyryl CAMP is resistant to hydrolysis 
by phosphodiesterase. Insulin inhibited the lipolytic action of 
isoproterenol, glucagon, adenosine deaminase (alone or in 
combination with lipolytic hormones), and forskolin. In these 
conditions, adenylylcyclase is stimulated through different 
mechanisms (see Fig. 2). Because the action of insulin is 
downstream of adenylylcyclase, it can inhibit the lipolytic 
action of this variety of stimulating agents. 
Our previous studies indicated that the antilipolytic effect 
of EGF involves the regulation of G protein interaction in the 
control of adenylylcyclase (4). Therefore, it was important to 
compare EGF and insulin antilipolytic effects directly. The 
results obtained indicate that the effects are mediated by 
different mechanisms. If  EGF were activating a phosphod- 
iesterase, then its antilipolytic effect 1) would not disappear 
when adenosine deaminase was added to the cell suspen- 
sion, and 2) would be observed in forskolin-stimulated cells. 
TABLE 3. Bisindolylmaleimide GF 109203X does not interfere 
with the effect of EGF on Isoproterenol-stimulated lipolysis 
Lipolysis (nmol glyceroV30 min X lo6 cells) 
-GF 109203X +GF 109203X (2 I*~) 
Control 103 * 2 88 -t 2 
+ PMA (100 nM) 114 k 2” 88 -r 1 
+ EGF (100 nM) 97 f 1” 78 i- 2” 
Isolated adipocytes were incubated at 37 C with or without the 
bisindoylmaleimide GF 109203X (2 FM) for 30 min before the addition 
of isoproterenol (final concentration: 100 nM; control), isoproterenol 
with PMA (+ PMA), or isoproterenol with EGF (+ EGF) in equal 
volumes. Then, a sample was taken (zero time) and another sample 
was taken 30 min afterwards to determine lipolysis. Results are the 
mean + SE of triplicate values. 
= P < 0.05. 
The conclusion that the antilipolytic effect of EGF is mediated 
by a different mechanisms to that of insulin is further sup- 
ported by an additional observation reported herein (and 
shown in Fig. 1): EGF potentiated the effect of a maximal dose 
of insulin. 
The use of the phosphatidylinositol 3-kinase inhibitor 
wortmannin (31) revealed that phosphatidylinositol3-kinase 
is required for the antilipolytic action of insulin (16), and for 
the phosphorylation and activation of the low Km (cGMP- 
inhibited) phosphodiesterase (17). It have been recently 
shown that wortmannin and its structural analogue deme- 
thoxyviridin can also inhibit phospholipase A, in Swiss 3T3 
cells (39). Therefore, the involvement of phosphatidylinositol 
3-kinase in insulin antilipolysis might be reevaluated. The 
activation of phosphatidylinositol3-kinase is a common fea- 
ture for many growth factors in many cells (13). However, 
because wortmannin affected very moderately the effect of 
EGF on isoproterenol-stimulated lipolysis, we conclude that 
phosphatidylinositol3-kinase, and other wortmannin sensi- 
tive substrates, do not contribute (or contribute very mod- 
estly) to EGF antilipolysis. 
In search of differences in EGF and insulin signalling, we 
focused on Cazt because insulin does not increase intracel- 
lular Ca2+ in adipocytes (33) and, although it was mentioned 
that EGF had no effect on cytosolic Ca2+ in mature adipo- 
cytes (33), it is known that the EGF receptor phosphorylates 
the y-isoform of phosphoinositide-specific phospholipase C 
(40). This effect of EGF results in the increase in cytosolic free 
Ca2+ concentration in many cells types including NIH 3T3 
cells (41). We found that EGF, but not insulin, increased this 
messenger in isolated adipocytes (see Fig. 4). Indeed, this 
effect was much milder than that of vasopressin. The results 
obtained in a Ca2+-free medium indicate that the increase in 
cytosolic free Ca 2t, induced by both EGF and vasopressin, 
depends on extracellular Ca2’ either because they stimulate 
Ca 2+ inflow, or because extracellular Ca2+ is required for 
maintenance of the internal stores. 
Vasopressin infusion to fasted rats has a rapid antilipolytic 
effect (42). These authors did not observe such an effect in 
isolated adipocytes (43). We report here that vasopressin, like 
EGF, decreases the CAMP signal and the lipolytic response of 
adipocytes to isoproterenol. Our results further suggest that 
EGF and vasopressin decrease the lipolytic response of iso- 
lated adipocytes through similar mechanisms. This is based 
on the following: 1) both had similar antilipolytic potencies; 
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2) both decreased isoproterenol- but not forskolin-stimulated 
lipolysis and CAMP levels; 3) both antilipolytic effects were 
completely dependent on the presence of free Ca2+ in the 
incubation medium; and 4) maximal doses of each peptide 
did not induce additive effects. It could be argued that al- 
though both induced similar antilipolytic effects, vasopressin 
increased intracellular Ca2+ concentration more than 5-fold 
whereas EGF did SO only 1.2-fold. However, in dose-re- 
sponse experiments comparing the increase in cytosolic Ca2+ 
and the ability of vasopressin to decrease isoproterenol-stim- 
ulated lipolysis, we observed that such a large increase in 
Cazt is not required to reach maximal antilipolysis (see Fig. 
5). In fact, lipolysis was very sensitive to moderate increases 
in Ca2+. Therefore, we propose that both EGF and vasopres- 
sin decrease hormone-stimulated lipolysis through a similar 
Ca2+-dependent mechanism. 
Among the mediators of Ca2~+, we studied the involvement 
of protein kinase C in the antilipolytic effect of EGF. Protein 
kinase C is involved in some of the effects of EGF in several 
cell types, including the late phase activation of p70shk (44,45) 
and the stimulation of phospholipase D (46) in 3T3 cells. 
Other effects of EGF are, however, independent of protein 
kinase C (47, 48). Our results suggest that protein kinase C 
induces an effect on CAMP and lipolysis opposed tot that of 
EGF. This conclusion is based in the studies involving PMA 
and the bisindolylmaleimide GF 109203X. It should be noted 
that PMA only activate diacylglycerol-stimulated protein ki- 
nase C isoforms (49). Among them, those which are also 
Ca2’-dependent: cy, PI/PII, and y  (50). Those isoforms are 
also the most sensitive to GF 109203X (51). Therefore, our 
results, although do not exclude the involvement of all pro- 
tein kinase C isoforms (specially & which is completely in- 
sensitive to PMA (50) and rather insensitive to the GF 
109203X (51)), do exclude the involvement of the classical 
protein kinase C isoforms which are sensitive to both PMA 
and GF 109203X. 
The effect of protein kinase C on the CAMP generating 
system is complex and appears to be cell-specific (52). 
Naghshineh et al. (53) found that purified protein kinase C 
activates adenylylcyclase from adipocyte membranes. In ad- 
dition to this effect, it is conceivable that protein kinase C 
could phosphorylate and inactivate the function of some Gi 
protein in adipocytes, as it was observed in intact hepato- 
cytes (54). Our results showing that PMA decreases the sen- 
sitivity of isoproterenol-stimulated lipolysis to the inhibition 
by PIA (Fig. 8), and those of Chambaut-Guerin and Thomo- 
poulos (55) (who observed that the effect of PMA on CAMP 
was prevented by the pretreatment of the cells with pertussis 
toxin), are in keeping with this latter hypothesis. The results 
reported herein (Fig. 8) indicate that EGF produces an op- 
posite effect to that of Ca2+ -sensitive protein kinase C iso- 
forms on the sensitivity of adenylylcyclase to Gi proteins: 
EGF increase the sensitivity of isoproterenol-stimulated ad- 
enylylcyclase to the inhibitory effect of PIA. In a previous 
report (4), we showed that the effect of EGF on PIA-inhibited 
lipolysis was only observed if adenylylcyclase was stimu- 
lated by G,-coupled receptors. 
In conclusion, we observed that EGF and insulin promote 
similar effects in mature adipocytes. Although both EGF and 
insulin receptors share common capabilities in their respec- 
tive mechanisms of action, our results demonstrate that, at 
least one of these effects, the antilipolysis, is mediated by 
different mechanisms. In particular, the effect of EGF re- 
quires of Ca2’-, although Ca’+-activated protein kinase C 
isoforms are not involved. 
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